Singapore and Hong Kong will establish the first reciprocal travel bubble that will not require quarantine upon arrival, the Singapore government said Thursday.
The agreement was reached between Singapore Transport Minister Ong Ye Kung and Hong Kong's commerce secretary, Edward Yau.
A launching date for the bubble had not been specified as the governments still needing to iron out details over the coming weeks.
People traveling under the arrangement will need to test negative for the coronavirus before boarding their flights.
There are no limitations regarding travel purposes, allowing travelers to move freely in either city without a predetermined itinerary.
Airlines should also operate dedicated routes where transit passengers are not allowed.
Ong described the plan as a "safe, careful but significant step" for reviving air travel, and "provide a model" for collaboration with other countries.
He added that it is significant that the two regional aviation hubs have collaborated on the air travel bubble.
Ong noted that based on his research, it is the first-ever reciprocal travel bubble.


Standard Chartered Expands Hedge Fund Access for Wealth Clients
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
REPAY Stock Rises After Visa Platform Connect Collaboration
Google to Move All Pixel Production Out of China by 2027
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook 



